Znaczenie esketaminy w leczeniu depresji lekoopornej. Czy okaże się lekiem przełomowym?

Abstract

Esketamine opens a new chapter in treatment-resistant depression. It is used more and more often, because the therapeutic methods used so far do not provide fully satisfactory results. This article is a review of the most important information regarding the efficacy of esketamine and according to fighting depression and its influence on the glutamate system. The review also contains a short description of the most common adverse events, including the research of different stages of therapy on which they can appear. It turns out that appropriate influence on the glutamate system reduces symptoms of depression. Intranasal administration of esketamine quickly improves the condition of patients with treatment-resistant depression and reduces the risk of suicide. Long-term studies are still going on and their results should provide necessary information for improvement of this therapeutic method for treatment-resistant depression.